Cargando…
Therapeutic Re-Activation of Protein Phosphatase 2A in Acute Myeloid Leukemia
Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase that is required for normal cell growth and development. PP2A is a potent tumor suppressor, which is inactivated in cancer cells as a result of genetic deletions and mutations. In myeloid leukemias, genes encoding PP2A subunits are gene...
Autores principales: | Ramaswamy, Kavitha, Spitzer, Barbara, Kentsis, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313608/ https://www.ncbi.nlm.nih.gov/pubmed/25699237 http://dx.doi.org/10.3389/fonc.2015.00016 |
Ejemplares similares
-
Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia
por: Arriazu, Elena, et al.
Publicado: (2016) -
Peptidomimetic blockade of MYB in acute myeloid leukemia
por: Ramaswamy, Kavitha, et al.
Publicado: (2018) -
Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023) -
Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
por: Tasian, Sarah K., et al.
Publicado: (2014) -
Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia
por: Wingelhofer, Bettina, et al.
Publicado: (2019)